Genetics of familial amyloidotic polyneuropathy in a Hong Kong Chinese kindred

Acta Neurologica Scandinavica

Volumn 107, Issue 6, 2003, Pages 419-422

  Mak, C M ^a   Lam, C W ^b   Fan, S T ^c   Liu, C L ^c   Tam, Sidney C ^a  

^a QUEEN MARY HOSPITAL   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Amyloid; Familial amyloidotic polyneuropathy; Hong Kong Chinese; Transthyretin gene

Indexed keywords

ALANINE; CYTOSINE; DNA; MUTANT PROTEIN; PREALBUMIN; RESTRICTION ENDONUCLEASE; THYMINE; VALINE;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CASE REPORT; CHINESE; CODON; DNA DETERMINATION; DNA SEQUENCE; EXON; FAMILIAL AMYLOID POLYNEUROPATHY; FAMILY STUDY; FEMALE; GENE MUTATION; GENETICS; HISTOPATHOLOGY; HONG KONG; HUMAN; LIVER TRANSPLANTATION; MUTATIONAL ANALYSIS; RESTRICTION MAPPING; SIBLING; SYMPTOM;

ADULT; ALANINE; AMYLOID NEUROPATHIES; ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; HONG KONG; HUMANS; MUTATION; PEDIGREE; POLYNEUROPATHIES; PREALBUMIN; VALINE;

EID: 0037507293     PISSN: 00016314     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0404.2003.00047.x     Document Type: Article

References (14)

1. UEMICHI T, GERTZ MA, BENSON MD. A new transthyretin variant (Series 24) associated with familial amyloid polyneuropathy. J Med Genet 1995;32:279-81.
2. ANDRADE C. A peculiar form of peripheral neuropathy. Familial atypical generalized amyloidosis with special involvement of the peripheral nerves. Brain 1952;75:408-27.
3. CHANG CM, YU YL, WONG M, NG TH, WOO E, HUANG CY. Type 1 familial amyloid polyneuropathy in a Chinese family. Acta Neurol Scand 1989;79:391-6.
4. JONES LA, SKARE JC, COHEN AS, HARDING JA, MILUNSKY A, SKINNER M. Familial amyloidotic polyneuropathy: a new transthyretin position 30 mutation (alanine for valine) in a family of German descent. Clin Genet 1992;41:70-3.
5. PLANTE-BORDENEUVE V, SAID G. Transthyretin related familial amyloid polyneuropathy. Curr Opin Neurol 2000;13:569-73.
6. BOOTH DR, TAN SY, HAWKINS PN, PEPYS MB, FRUSTACI A. A novel variant of transthyretin, 59Thr- 〉 Lys, associated with autosomal dominant cardiac amyloidosis in an Italian family. Circulation 1995;91:962-7.
7. JONSEN E, SUHR OB, TASHIMA K, ATHLIN E. Early liver transplantation is essential for familial amyloidotic polyneuropathy patients' quality of life. Amyloid 2001;8:52-7.
8. HERLENIUS G, LARSSON M, ERICZON BG. Results from the familial amyloidotic polyneuropathy world transplant registry. Transplantation Proc 2001;33:2454.
9. HUND E, LINKE RP, WILLIG F, GRAU A. Transthyretin-associated neuropathic amyloidosis. Pathogenesis Treatment. Neurology 2001;56:431-5.
10. PALHA JA, BALLINARI D, AMBOLDI N et al. 4′-Iodo-4′-deoxydoxorubicin disrupts the fibrillar structure of transthyretin amyloid. Am J Pathol 2000;156:1919-25.
11. ALTLAND K, WINTER P. Potential treatment of transthyretin-type amyloidoses by sulfite. Neurogenetics 1999;2:183-8.
12. KLABUNDE T, PETRASSI HM, OZA VB, RAMAN P, KELLY JW, SACCHETTINI JC. Rational design of potent human transthyretin amyloid disease inhibitors. Nat Struct Biol 2000;7:312-21.
13. TANAKA K, YAMADA T, OHYAGI Y, ASAHARA H, HORIUCHI I, KIRA. J. Suppression of transthyretin expression by ribozymes: a possible therapy for familial amyloidotic polyneuropathy. J Neurol Sci 2001;183:79-84.
14. ALMEIDA MR, ALVES IL, SAKAKI Y, COSTA PP, SARAIVA MJ. Prenatal diagnosis of familial amyloidotic polyneuropathy: evidence for an early expression of the associated transthyretin methionine 30. Hum Genet 1990;85:623-6.